- The four core endpoints listed by OECD TG 236 (OECD, 2013) are indicated in bold. Frequency of occurrence:
—frequent and/or at concentrations < LC10;
— ≤ 20% of exposed organisms and/or only at concentrations > LC10;
—not observed for this compound
- * Additional determination at 120 and/or 144 hpf (cf. Table 1); # no symptoms of acute lethality at highest solubility in a final DMSO concentration of 1 %; $ no differentiation for specific spinal cord deformations; endpoints grouped under general “spinal cord malformation”